Kavrul Kayaalp, G. Et Al. 2023. Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.. Pediatric rheumatology online journal , vol.21, no.1 , 140.

Kavrul Kayaalp, G., Çağlayan, Ş., DEMİRKAN, F. G., Guliyeva, V., Otar Yener, G., Öztürk, K., ... Demir, F.(2023). Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.. Pediatric rheumatology online journal , vol.21, no.1, 140.

Kavrul Kayaalp, Gülşah Et Al. "Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.," Pediatric rheumatology online journal , vol.21, no.1, 140, 2023

Kavrul Kayaalp, Gülşah K. Et Al. "Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.." Pediatric rheumatology online journal , vol.21, no.1, pp.140, 2023

Kavrul Kayaalp, G. Et Al. (2023) . "Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.." Pediatric rheumatology online journal , vol.21, no.1, p.140.

@article{article, author={Gülşah KAVRUL KAYAALP Et Al. }, title={Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.}, journal={Pediatric rheumatology online journal}, year=2023, pages={140} }